Latest Articles

Publication Date
Burden and Risk Factor Patterns of Reproductive System Tumors and Non-Tumor Diseases Among Asian Women, 1990-2021: Evidence from the GBD Study.

Female reproductive system diseases, including malignant tumors such as breast, ovarian, and uterine cancers, and non-neoplastic disorders such as uterine fibroids, endometriosis, polycystic ovary syndrome (PCOS), infertility, and premenstrual syndrome …

Published: Feb. 11, 2026, midnight
FBXW7 suppresses cell proliferation, migration, and epithelial-mesenchymal transition in endometrioid ovarian carcinoma.

Epithelial ovarian carcinoma is a common gynecologic malignancy. Evidence from several studies suggests that subtypes of this cancer-specifically clear-cell ovarian carcinoma and endometrioid ovarian carcinoma (ENOC)-are associated with endometriosis. FBXW7 …

Published: Feb. 11, 2026, midnight
MSK Endometrial Cancer e-Tumor Board - Medscape

MSK Endometrial Cancer e-Tumor Board Medscape

Published: Feb. 10, 2026, 11:06 p.m.
Why is Inoperable Endometrial Cancer Relevant at the 2026 ACRO Summit? - CancerNetwork

Why is Inoperable Endometrial Cancer Relevant at the 2026 ACRO Summit? CancerNetwork

Published: Feb. 10, 2026, 8:43 p.m.
Robotic-assisted surgery for gynecological cancers - Penn Medicine

Robotic-assisted surgery for gynecological cancers Penn Medicine

Published: Feb. 10, 2026, 6:30 p.m.
Not just overweight: Qld scientists expose hidden cancer risk to women - Gold Coast Bulletin

Not just overweight: Qld scientists expose hidden cancer risk to women Gold Coast Bulletin

Published: Feb. 10, 2026, 2:08 p.m.
Not just overweight: Qld scientists expose hidden cancer risk to women - The Courier Mail

Not just overweight: Qld scientists expose hidden cancer risk to women The Courier Mail

Published: Feb. 10, 2026, 2:03 p.m.
Not just overweight: Qld scientists expose hidden cancer risk to women - The Chronicle | The Chronicle

Not just overweight: Qld scientists expose hidden cancer risk to women The Chronicle | The Chronicle

Published: Feb. 10, 2026, 2:01 p.m.
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment - IBTimes India

AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment IBTimes India

Published: Feb. 10, 2026, 11:57 a.m.
AstraZeneca Pharma India Receives CDSCO Approval for Imfinzi Cancer Treatment - scanx.trade

AstraZeneca Pharma India Receives CDSCO Approval for Imfinzi Cancer Treatment scanx.trade

Published: Feb. 10, 2026, 10:22 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!